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1. Introduction 
In a number of species, hepatic tyrosine amino- 
transferase (TAT) activity increases rapidly in response 
to stress occassioned by nutritional or hormonal 
imbalance [l-5]. To a large extent the activity 
changes observed are attributable to direct hormonal 
effects on the rates of TAT synthesis or degradation 
in the liver [6-91. TAT is the first enzyme in the 
catabolic pathway and is subject to numerous hor- 
monal control mechanisms; it has therefore been pro- 
posed as the rate limiting enzyme for hepatic tyrosine 
catabolism [lo]. There is, however, no direct evidence 
for this. From measurements of the rate of metab- 
olism of specifically labelled tyrosine in liver cell sus- 
pensions, we have shown that TAT is indeed rate lim- 
iting for tyrosine breakdown within the intact cell. 
Comparison of enzyme activities in extracts with the 
rates of flux through TAT in whole cells under various 
conditions indicates that the enzyme is subject to 
regulation by several distinct factors in vivo. 
2. Materials and methods 
L[carboxyl-“C]Tyrosine (60 Ci/mol) and (hy- 
droxy- [ 14C]methyl)inulin (500 Ci/mol) were obtained 
from the Radiochemical Centre, Amersham, Bucks. 
Aminooxyacetate was obtained from Sigma, Poole, 
Dorset and all other chemicals and biochemicals were 
from the suppliers mentioned in [ 11-I 3 1. 
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Details of the animals used in this study and the 
methods of hepatocyte isolation and viability assess- 
ment have been given [ 11 ,131. Hepatocytes (2-3 mg 
dry wt) were incubated for the times stated in 1.2 ml 
final vol. minimum essential medium (Eagles) con- 
taining 10% (v/v) dialysed, charcoal-treated foetal calf 
serum [ 13 1. When present, hormones were added as 
5 or 10 ~1 portions immediately before incubation 
[13]. Incubation was at 37°C with orbital shaking 
[ 111. After the desired incubation time TAT was 
extracted from hepatocytes and assayed radiometri- 
tally [ 121. A modification of this assay was also used 
to measure TAT flux (as H,O production) in the 
hepatocyte during incubation. L-[side c/~ain-2,3-~H]- 
Tyrosine was added to cells at the start of incubation 
(final spec. act. 2.06 &i/,umol tyrosine); the reac- 
tions were terminated by inhibition of transaminase 
activity with aminooxyacetate (tinal cont. 1 mM) 
[ 141. Preliminary experiments indicated that the 
presence of aminooxyacetate throughout 6 h incuba- 
tions completely inhibited 3H,0 production. Follow- 
ing centrifugation (12 000 X g, 4”C, 2 min), 50 1.11 
portions of supernatants were added to 4.50~1 charcoal 
(Norit GSX) (20 mg/ml in 0.06% (w/v) bovine serum 
albumin). After mixing, the contents of the tubes 
were centrifuged (12 000 X g, 4”C, 2 min). Because 
tyrosine binds quantitatively to charcoal [ 121, counts 
remaining in the supernatant are solely 3Hz0. Portions 
(2.50~1) of this supernatant were counted in 1 ml PCS. 
The production of 14C02 from L-[carboxyl-14C]- 
tyrosine was determined in cell incubations in glass 
vials (Kontes Glass Co., Wineland, NJ) fitted with 
centre wells; 14C02 was trapped in phenylethylamine: 
methanol (1: 1, v/v) [ 111. The final specific activity 
in incubations of L- [cavboxyl-14C] tyrosine was 
0.045 &i/pmol. 
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Intracellular tyrosine concentrations and specific 
activities were determined after separation of hepato- 
cytes from medium (20-30 mg cells dry wt in 10 ml 
medium) in special separation tubes [ 151. Carrydown 
of medium with cells was estimated with (hydroxy- 
[ 14C]methyl)inulin (final spec. act. 0.26 nCi/pmol). 
Intracellular contents were extracted with 4% (v/v) 
HC104 and 50 ~1 portions of extracts were counted 
before and after treatment with 450 ~1 Norit GSX 
suspension to measure the counts contributed by 
3Hz0 plus L-[side c/~ain-2,3-~H] tyrosine and 3Hz0 
only, respectively. The remaining volumes were neu- 
tralized and applied to columns of Amberlite CG 120 
(H+) (0.5 X 7 cm). After each column had been washed 
with 5 bed vol. water, bound tyrosine was eluted with 
5 ml 5 M NH40H and the eluants were freeze-dried. 
The residues were dissolved in 100 ~1 H,O and tyrosine 
contents were measured fluorimetrically [ 161. 
Values are means + SEM for the number of experi- 
ments indicated. In certain cases a representative 
experiment has been chosen and results are then pre- 
sented as means f SD for the triplicate samples at each 
point. 
3. Results and discussion 
Measurements of the intra- and extracellular con- 
centrations of tyrosine and of the specific activity of 
the ammo acid indicated complete equilibration of 
tyrosine between cellular water and medium during 
incubations of up to 2 h. We have therefore based 
flux measurements on the specific activity of the 
medium tyrosine. The rate of release of 3Hz0 from 
L- [side chain-2,3-3H] tyrosine was dependent on the 
TAT activity and nutritional origin of the hepatocytes 
(fig.1). Significant 3Hz0 formation was observed after 
5 min incubation. Initial rates of production of 3H,0 
were linear but some decrease was observed between 
2-4 h incubation. During this time, the TAT activity 
of liver cell suspensions also decreases [131, but the 
decline in rate may be, in part, attributable to dk- 
creased extracellular tyrosine specific activity as a 
consequence of proteolysis [ 171. 
Results obtained from 3Hz0 release by three prep- 
arations of fed rat hepatocytes indicated that tyro- 
sine was metabolised at 0.103 k 0.007 nmol . min-’ . g 
dry cells-‘; fluorimetric analysis of the medium of 
these preparations showed the loss of 0.098 prnol 
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Fig.1. Rates of production of ‘H,O from L-[side chain-2,3- 
3H]tyrosine during hepatocyte incubations. Details of experi- 
mental conditions and isotope addition are given in the text. 
Initial medium tyrosine concentration was 0.18 mM. 
(A) Values are means + SEM for the conditions as follows: 
Symbol Nutritional No. Initial TAT activity &mol 
state of rat expt. tyrosine metabolized . 




Fed, intact 4 1.51 ?; 0.16 
Fed, adrenal- 
ectomized 2 0.98 ?: 0.73 
48 h starved, 
intact 3 2.12 k 0.21 
(B) Representative experiment with hepatocytes from fed 
rats. Values are means of triplicate determinations + SD 
supports the contention that 3Hz0 production is a 
good measure of tyrosine metabolism in cell suspen- 
sions. This observation also suggests that the isotope 
effect noted in assays of TAT in vitro with L-[side 
chain-2,3-3H] tyrosine [ 121 is not found under cell 
incubation conditions. Similar discrepancies in respect 
of isotope effects resulting from differences in rate 
constants of partial reactions under various condi- 
tions have been noted previously [ 18,191. 
The absence of a 3H-isotope effect was further 
confirmed in experiments in which the rates of metab- 
olism as a function of tyrosine concentration were 
measured. The apparent Km for tyrosine is similar 
for the enzyme both isolated in cell homogenates and 
the whole cell incubations. In two independent experi- 
ments (with triplicate determinations in each), the 
maximal activity of TAT in cell extracts was apparently 
only 1.05 pmol . min-’ . g dry wt-’ as assayed by the 
3Hz0 release method at 30°C [ 121. When the isotope 
29 
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Table 1 
Comparison of the rates of 14C02 release from L-[carboxyl- 
“‘Cjtyrosine and 3H,0 production from L-[side chain-2,3- 
3H]tyrosine by hepatocytes from fed rats 
_ 
Time Tyrosine metabolised (nmol/mg dry wt) 
01) - 
Substrate: L-[&e cfzait~-2,3-~1i]- L-[carbos$-14C]- 
Tyrosine Tyrosine 
1 7.16 + 0.65 8.07 + 0.90 
2 15.87 I 0.83 14.05 f 1.05 
3 18.12 + 0.63 18.77 t 1.40 
Procedures for incubations were as given in the text. initial 
tyrosine concentration was 0.18 mM. Values are means t 
SEM from three independent observations 
effect noted earlier 1121 and the temperature are taken 
into account, this activity is corrected to 10.1 pmol . 
min-1 . g dry wt-’ at 37°C. This value is greater than 
that actually observed simultaneously in whole cell 
incubations with saturating concentrations of tyrosine 
(3.12 pm01 . mm-‘. g dry wt-‘, again taking no 
account of potential isotope effects). The assay sys- 
tem in vitro, however, contains 100 mM 2-oxogluta- 
rate. The reported Km value of TAT for 2-oxogluta- 
rate is 2.1 mM [20]: in intact liver cells, the cytosolic 
concentration of 2-oxoglutarate is -1 mM [21,22]. 
Taking this factor into account, the calculated activ- 
ity of TAT in cell incubations is decreased from 
10.1-3.3 pmot . min-' . g dry wt-‘, a value close to 
that found. 
The rates of substrate flux through TAT and 
p-hydroxyphenylpyruvate oxidase using L- [side chain- 
2,3-3H] tyrosine and L-[carbox~+l-r4C] tyrosine, respec- 
tively, were found to be similar (table l), and to be 
stimulated by glucagon (2 X 10m7 M) to the same 
extent (127.7 + 4.6 and 132.2 2 6.4%) of control, 
respectively; 3 independent obs. If TAT catalysed an 
‘equilibrium’ reaction, then the rate of 3H20 fonna- 
tion should exceed the rate of 14C02 production 
because of rapid exchange of [3H]tyrosine with intra- 
cellular water. Therefore one may conclude that TAT 
probably catalyses the rate-limiting reaction in tyrosine 
catabolism, despite its unpromising equ~ibrium con- 
stant. 
Exposure of isolated cells to glucagon and tri- 
amcinolone lead to increased TAT activity (table 2). 
Glucagon produces an effect within 2 h which was 
decreased by 6 h; triamcinolone, however. is only 
seen to be effective after a lag phase 181. Cell tyrosine 
metabolism was silnulataneously increased in the 
presence of each hormone individually with triamci- 
nolone having greater effects after 6 h than at shorter 
incubation periods. In neither case was the increase 
of tyrosine metabolism as marked as that of TAT 
activity. Both tyrosine I~etaboIism and TAT activity 
maximally increased at similar concentrations of hor- 
mones (fig.?), so that the lack of correspondence 
between these parameters cannot be a result of differ- 
ential sensitivities. Neither hormone increased the 
intra-cellular concentration or specific activity of 
tyrosine (not shown). We feel that the extent of stim- 
ulation of tyrosine metabolism by the intact cell prob- 
ably reflects the internal concentration of Soxogluta- 
rate. Although increasing the amount of potentially 
active enzyme, glucagon also decreases cellular 2-0x0- 
glutarate concentrations 123,341 and thus produces 
much smaller effects on tyrosine flux than those 
expected from assay of TAT activity under the opti- 
mal conditions employed in vitro. No information is 
available on the effects of triamcinolone on cellular 
metabolites. 
There is no simple correlation between the activity 
of TAT in extracts and the flux from tyrosine to 
p-hydroxyphenylpyruvate. Exposure of cells to both 
glucagon and triamcinolone together results in a much 
Table 2 










128.5 f 2.7 
133.5 f 2.3 
TAT activity 
166.6 + 6.4 
169.7 + 8.3 
144.9 i. 8.9 
Trramcinolone (lo-* M) 
Tyrosine metsbohsm 
- 
116.4 f 1.3 
123.9 i 3.1 
142.9 + 3.7 
TAT activrty 
150.1 + 6.1 
240.3 + 14.7 
208.0 * 11 .l 
Procedures were as described in the text. Initial medium tyrosine was 0.18 mhf. Values are expressed as % of the respective con- 
trols at each time point. Results are means from 4 mdependent obs. f SEM 
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HORMONE CONCENTRATION (- LOG M) 
Fig.2. Effect of glucagon and triamcinolone concentration on TAT activity and the production of ‘H,O from L-[side chain-2,3- 
3H]tyrosine. Hepatocytes from fed rats were incubated for 5 h in the presence of 0.18 mM tyrosine. Values are expressed as % 
increasesover control at 5 h, and are means + SD of 3 experimental samples. Rates of cellular production of 3H,0: (A) + glucagon; 
(0) + triamcinolone. Rates of TAT activity measured in vitro: (A) + glucagon; (m) + triamcinolone 
greater increase in assayable activity than in catabolism 
of tyrosine (table 3). Thus, enzyme protein concen- 
tration is not the sole determinant of activity in vivo. 
Whereas the effects of the triamcinolone required 
>2 h incubation to become appreciable, some effect 
of glucagon was measurable 30 min after addition of 
the hormone (not shown). This would be consistent 
with a post-translational modification of the enzyme, 
as suggested [2.5] and experiments are in progress to 
investigate this possibility. 
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